Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

European Journal of Cancer

Volumn 47, Issue 3, 2011, Pages 354-360

  Burmeister, Bryan H ^a   Thomas, Janine M ^b   Burmeister, Elizabeth A ^c   Walpole, Euan T ^a   Harvey, Jennifer A ^a   Thomson, Damien B ^a   Barbour, Andrew P ^a,b   Gotley, David C ^a,b   Smithers, B Mark ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Adenocarcinoma; Chemoradiation therapy; Neoadjuvant therapy; Oesophageal cancer; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; DRUG DOSE REDUCTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; FEMALE; FEVER; HEART DISEASE; HISTOPATHOLOGY; HUMAN; INFECTION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 79251595542     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.09.009     Document Type: Article

References (28)

1. K. Nygaard, S. Hagen, and H.S. Hansen Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy - the second Scandinavian trial in esophageal cancer World J Surg 16 1992 1104 1110
2. P. Schlag Randomized trial of preoperative chemotherapy for squamous cell carcinoma of the esophagus Arch Surg 127 1992 1446 1450
3. T. Maipang, P. Vasinanukorn, and C. Petpichetchian Induction chemotherapy in the treatment of patients with carcinoma of the esophagus J Surg Oncol 56 1994 191 197
4. T.C. Kok, J. van Lanschot, and P.D. Siersma Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized trial Proc Am Soc Oncol 16 1997 227a [abstract 984]
5. S.M.B. Law, M. Fok, and S. Chow Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial J Thorac Cardiovasc Surg 114 1997 210 217
6. J. Roth, H. Pass, and M. Flanagan Randomized clinical trial preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg 96 1998 242 248
7. E. Ancona, A. Ruol, and S. Santi Only pathological complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma Cancer 91 2001 2165 2174
8. C. Apinop, P. Puttisak, and N. Preecha A prospective study of combined therapy in esophageal cancer Hepato-Gastroenterology 41 1994 391 393
9. E. Le Prise, P.L. Etienne, and B. Meunier A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1994 1779 1784
10. J. Bosset, M. Gignoux, and J. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell carcinoma of the esophagus New Eng J Med 337 1997 161 167
11. J. Lee, S. Park, and S. Kim A single institutional phase II trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma Ann Oncol 15 2004 947 954
12. D.P. Kelsen, R. Ginsberg, and T.F. Pajak Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer New Eng J Med 339 1998 1979 1984
13. Medical Research Council Oesophageal Cancer Working Party Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial Lancet 359 2002 1727 1733
14. T.N. Walsh, N. Noonan, and D. Hollywood A comparison of multimodal therapy and surgery for esophageal adenocarcinoma New Engl J Med 335 1996 462 467
15. S.G. Urba, M.B. Orringer, and A. Turrissi Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 9 2001 305 313
16. B.H. Burmeister, B.M. Smithers, and V. Gebski Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus Lancet Oncol 6 2005 659 668
17. J. Tepper, M.J. Krasna, and D. Niedziwiecki Phase III trimodality therapy with cisplatin, fluorouracil, radiotherapy and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
18. F. Fiorca, D. Di Bona, and F. Schepis Preoperative chemoradiotherapy for oesophgeal cancer: a systematic review and meta-analysis Gut 53 2004 925 930
19. I.G. Kaklamanos, G.R. Walker, and K. Ferry Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol 10 2003 754 761
20. J.D. Urschel, and H. Vasan A meta-analysis of randomized trials that compare neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538 543
21. V. Gebski, B. Burmeister, and B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
22. P.G. Thirion, A. Michiels, and A. Le Maitre Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma J Clin Oncol 25 2007 200s
23. H.L. Jin, H. Zhu, and T.S. Ling Neoadjuvant chemoradiotherapy for resectable esophageal carinoma: a meta-analysis World J Gastrenterol 15 2009 5983 5991
24. B.P.L. Wijnhoven, J.J.B. van Lanschot, and H.W. Tilanus Neoadjuvant chemotherapy for esophageal cancer: a review of meta-analyses World J Surg 33 2009 2606 2614
25. B.L. Brucher, K. Becker, and F. Lordick The clinical impact of histopathologic response assessment by residual tumour cell quantification in esophageal squamous cell carcinoma Cancer 106 2006 2119 2127
26. P.M. Schneider, S.E. Baldus, and R. Metzger Histomorphologic tumour regression and lymph node metastasis determine prognosis following neoadjuvant radiochemotherapy for oesophageal cancer: implication for response classification Ann Surg 242 2005 684 692
27. A.P. Barbour, M. Jones, and M. Gonen Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response Ann Surg Oncol 15 2008 2894 2902
28. M. Stahl, M.K. Walz, and M. Stuschke Phase II comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856